With respect to the substantial similarity criteria, the applicant asserted that TECVAYLI TM is not substantially similar to other currently available technologies because it has a distinct mechanism of action, with a novel approach to engage a patient's own T-cells to generate a myeloma-specific immune response, and is the first therapy of its type for the treatment of RRMM, and therefore meets the newness criterion
PMID 17959839
Cancel Anytime
Melanie Avalon: I always get worried because my mom has always said since I was little, she's like, The liver regenerates itself, but you've only got like one set of kidneys, or something, I don't know
Um CY, Prizment A, Hong CP, Lazovich DA, Bostick RM
Unterschiedliche Glutathion-Nahrungsergnzungsformen Glutathion ist in verschiedenen Formen als Nahrungsergnzung erhltlich